Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CYP1A2 |
| Upstream (Parents) |
|---|
| (<<) CDH22 → CYP1A2 |
| (<<) CNIH4 → CYP1A2 |
| (<<) EBP → CYP1A2 |
| (<<) IL23A → CYP1A2 |
| (<<) LOC100131581 → CYP1A2 |
| (<<) PDE4C → CYP1A2 |
| (<<) SLC34A3 → CYP1A2 |
| (<<) SPRR2G → CYP1A2 |
| (<<) T → CYP1A2 |
| (<<) TPSG1 → CYP1A2 |
| (<<) ZNF205 → CYP1A2 |
| Downstream (Children) |
|---|
| CYP1A2 → ASTN2 (>>) |
| CYP1A2 → CCDC108 (>>) |
| CYP1A2 → CEP170 (>>) |
| CYP1A2 → CREBBP (>>) |
| CYP1A2 → CSGALNACT2 (>>) |
| CYP1A2 → DRD4 (>>) |
| CYP1A2 → EP300 (>>) |
| CYP1A2 → FGF5 (>>) |
| CYP1A2 → GLS (>>) |
| CYP1A2 → GNB1 (>>) |
| CYP1A2 → GPR109B (>>) |
| CYP1A2 → IL1B (>>) |
| CYP1A2 → INE1 (>>) |
| CYP1A2 → KREMEN1 (>>) |
| CYP1A2 → NMNAT1 (>>) |
| CYP1A2 → PRKAA1 (>>) |
| CYP1A2 → PTEN (>>) |
| CYP1A2 → RASSF1 (>>) |
| CYP1A2 → RNF11 (>>) |
| CYP1A2 → SLMO2 (>>) |
| CYP1A2 → SMAD1 (>>) |
| CYP1A2 → SNX22 (>>) |
| CYP1A2 → TRIM32 (>>) |
| CYP1A2 → VANGL1 (>>) |
